Regular readers will know I’m a big fan of this innovation but it continues to amaze me how the main stream media seem to be so convinced that the appeal of this product is going to be in emerging market medicine. Watching this video you get the feeling that Market Watch isn’t aware that Pfizer (worth $145 billion) knocked up more than $10 Billion in sales of Lipitor (Atorvastatin) last year. Imagine the patient experience that mHealth service providers will be able to deliver when we can build biofeedback loops powered by such readily accessible and reliable data?
Want to learn more about the Pharma opportunity in mHealth? Join us in London on the 1-2 December for the Mobile Strategy for Pharma Conference (click here to get yourself a 20% discount and a copy of our “Mobile Strategy for Pharma” white paper).